Darnell A. Pouncil

Array ( [id] => 9916739 [patent_doc_number] => 20150071944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'STABLE ANTIBODY COMPOSITIONS AND METHODS OF STABILIZING SAME' [patent_app_type] => utility [patent_app_number] => 14/534776 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40190 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14534776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053367 [patent_doc_number] => 20160250329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'ANTIBODY COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/032870 [patent_app_country] => US [patent_app_date] => 2014-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20806 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15032870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864186 [patent_doc_number] => 20150044206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'IMMUNOGLOBULIN FORMULATION AND METHOD OF PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/524687 [patent_app_country] => US [patent_app_date] => 2014-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8861 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14524687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10233255 [patent_doc_number] => 20150118249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'Stable, Aqueous Antibody Formulations' [patent_app_type] => utility [patent_app_number] => 14/521870 [patent_app_country] => US [patent_app_date] => 2014-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25247 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 53 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11031417 [patent_doc_number] => 20160228371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'STABLE SOLID UNITS AND METHODS OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/029947 [patent_app_country] => US [patent_app_date] => 2014-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 84185 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14697719 [patent_doc_number] => 10376582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-13 [patent_title] => Buffer formulations for enhanced antibody stability [patent_app_type] => utility [patent_app_number] => 15/025088 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 19500 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11054477 [patent_doc_number] => 20160251439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'METHOD FOR PRODUCING POLYCLONAL ANTIBODIES USING AN ANTIGENIC COMPOSITION COMPRISING PROTEIN-CONTAINING MEMBRANE VESICLES' [patent_app_type] => utility [patent_app_number] => 15/027775 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5537 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12227532 [patent_doc_number] => 09914766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-13 [patent_title] => 'Method for immunizing an avian species' [patent_app_type] => utility [patent_app_number] => 14/493468 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24667 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11016824 [patent_doc_number] => 20160213777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'Novel Delivery Compositions and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 14/917491 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 36917 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916716 [patent_doc_number] => 20150071921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'LIQUID PROTEIN FORMULATIONS CONTAINING ORGANOPHOSPHATES' [patent_app_type] => utility [patent_app_number] => 14/483896 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27685 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12942664 [patent_doc_number] => 09833513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof [patent_app_type] => utility [patent_app_number] => 14/484053 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25886 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916715 [patent_doc_number] => 20150071920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'LIQUID PROTEIN FORMULATIONS CONTAINING WATER SOLUBLE ORGANIC DYES' [patent_app_type] => utility [patent_app_number] => 14/483880 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25116 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916719 [patent_doc_number] => 20150071925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'LIQUID PROTEIN FORMULATIONS CONTAINING VISCOSITY-LOWERING AGENTS' [patent_app_type] => utility [patent_app_number] => 14/484160 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37402 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974240 [patent_doc_number] => 20140377275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/473775 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 45226 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10613829 [patent_doc_number] => 09333256 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 14/464447 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 25159 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12384621 [patent_doc_number] => 09962440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-08 [patent_title] => Methods related to TIM 3, a TH1-specific cell surface molecule, for activating antigen presenting cells [patent_app_type] => utility [patent_app_number] => 14/464455 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 22769 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10813742 [patent_doc_number] => 20160159902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'STABILIZED ANTIBODY COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/907254 [patent_app_country] => US [patent_app_date] => 2014-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9088 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14258931 [patent_doc_number] => 10279009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-07 [patent_title] => Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen intensity, increasing antitumor efficacy [patent_app_type] => utility [patent_app_number] => 14/335766 [patent_app_country] => US [patent_app_date] => 2014-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 14 [patent_no_of_words] => 17440 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960366 [patent_doc_number] => 20140363394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'FORMULATION HAVING MOBILIZING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/323918 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2727 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298876 [patent_doc_number] => 20150183876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'HIGH PRESSURE REFOLDING OF MONOCLONAL ANTIBODY AGGREGATES' [patent_app_type] => utility [patent_app_number] => 14/323776 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11689 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323776 [rel_patent_id] =>[rel_patent_doc_number] =>)